Roche Global IT Solution Centre (RGITSC), Warsaw, Poland.
Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
PLoS Comput Biol. 2021 Jul 6;17(7):e1009131. doi: 10.1371/journal.pcbi.1009131. eCollection 2021 Jul.
Human immunogenetic variation in the form of HLA and KIR types has been shown to be strongly associated with a multitude of immune-related phenotypes. However, association studies involving immunogenetic loci most commonly involve simple analyses of classical HLA allelic diversity, resulting in limitations regarding the interpretability and reproducibility of results. We here present MiDAS, a comprehensive R package for immunogenetic data transformation and statistical analysis. MiDAS recodes input data in the form of HLA alleles and KIR types into biologically meaningful variables, allowing HLA amino acid fine mapping, analyses of HLA evolutionary divergence as well as experimentally validated HLA-KIR interactions. Further, MiDAS enables comprehensive statistical association analysis workflows with phenotypes of diverse measurement scales. MiDAS thus closes the gap between the inference of immunogenetic variation and its efficient utilization to make relevant discoveries related to immune and disease biology. It is freely available under a MIT license.
人类免疫遗传学变异以 HLA 和 KIR 类型的形式表现出来,与多种免疫相关表型密切相关。然而,涉及免疫遗传座的关联研究最常涉及对经典 HLA 等位基因多样性的简单分析,这导致结果的可解释性和可重复性受到限制。我们在这里提出了 MiDAS,这是一个用于免疫遗传学数据转换和统计分析的综合 R 包。MiDAS 将 HLA 等位基因和 KIR 类型的输入数据重新编码为具有生物学意义的变量,允许 HLA 氨基酸精细映射、HLA 进化分歧分析以及经过实验验证的 HLA-KIR 相互作用。此外,MiDAS 还能够实现具有不同测量尺度的表型的综合统计关联分析工作流程。因此,MiDAS 弥合了免疫遗传学变异推断与其有效利用之间的差距,有助于与免疫和疾病生物学相关的发现。它根据 MIT 许可证免费提供。